These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 350443)

  • 1. [Treatment of renal carcinoma with metastases].
    Artibani W; Breda G; Zattoni F; Graziotti P; Vancini P; Mazza G
    Chir Ital; 1978 Apr; 30(2):81-105. PubMed ID: 350443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors for predicting the success of immunotherapy in metastatic renal cell carcinoma].
    Schmitz-Dräger BJ; Jankevicius F; Otto T
    Urologe A; 1995 May; 34(3):195-9. PubMed ID: 7610511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for and results of nephrectomy for metastatic renal cell carcinoma.
    Middleton AW
    Urol Clin North Am; 1980 Oct; 7(3):711-7. PubMed ID: 6161461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced renal cell carcinoma.
    deKernion JB; Lindner A
    Prog Clin Biol Res; 1982; 100():641-59. PubMed ID: 6183675
    [No Abstract]   [Full Text] [Related]  

  • 5. Status of adjuvant therapy for renal cell cancer.
    Sagalowsky A; Donohue J
    J Indiana State Med Assoc; 1979 Jul; 72(7):521-4. PubMed ID: 383849
    [No Abstract]   [Full Text] [Related]  

  • 6. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
    Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
    Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible synergy of radiotherapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC).
    Brinkmann OA; Bruns F; Prott FJ; Hertle L
    Anticancer Res; 1999; 19(2C):1583-7. PubMed ID: 10365150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis and treatment of renal cell carcinoma.
    deKernion JB; Berry D
    Cancer; 1980 Apr; 45(7 Suppl):1947-56. PubMed ID: 6154520
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
    Pantuck AJ; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of metastatic renal cell carcinoma: current trends.
    Mohammed A; Shergill I; Little B
    Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of renal cell carcinoma with mediastinal lymph node metastasis by interleukin-2: a case report.
    Tokunaga M; Masuda A; Mukai M; Nakamura H; Iwaki K; Terachi T
    Tokai J Exp Clin Med; 2005 Jul; 30(2):111-5. PubMed ID: 16146201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Late metastasis in thyroid gland after nephrectomy for renal clear cell carcinoma].
    Pereira Arias JG; Acinas García O; Escobal Tamayo V; Emaldi Abasolo A; Prieto Ugidos N; Bildosola Aguirre A; Bernuy Malfaz C
    Actas Urol Esp; 1995 Jun; 19(6):468-72. PubMed ID: 8571807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrectomy for metastatic renal cell carcinoma and surgery for distant metastases.
    Van Poppel H; Baert L
    Acta Urol Belg; 1996 May; 64(2):11-7. PubMed ID: 8701800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing natural history of renal cell carcinoma.
    Pantuck AJ; Zisman A; Belldegrun AS
    J Urol; 2001 Nov; 166(5):1611-23. PubMed ID: 11586189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents.
    Köpke T; Bierer S; Wülfing C; Tiemann A; Hertle L; Herrmann E
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):763-71. PubMed ID: 19496713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.
    Franklin JR; Figlin R; Rauch J; Gitlitz B; Belldegrun A
    Semin Urol Oncol; 1996 Nov; 14(4):230-6. PubMed ID: 8946623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for metastatic renal cell carcinoma.
    McDermott DF; Rini BI
    BJU Int; 2007 May; 99(5 Pt B):1282-8. PubMed ID: 17441925
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metastatic kidney cancer: new therapeutic approaches].
    Negrier S; Mejean A; Oudard S; Escudier B
    Prog Urol; 2002 Sep; 12(4):703-8. PubMed ID: 12463140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The failure of infarction and/or nephrectomy in stage IV renal cell cancer to influence survival or metastatic regression.
    Flanigan RC
    Urol Clin North Am; 1987 Nov; 14(4):757-62. PubMed ID: 3314066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debulking nephrectomy in metastatic renal cancer.
    Flanigan RC
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6335S-41S. PubMed ID: 15448027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.